These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 23019314)

  • 1. The mechanisms of cachexia underlying muscle dysfunction in COPD.
    Remels AH; Gosker HR; Langen RC; Schols AM
    J Appl Physiol (1985); 2013 May; 114(9):1253-62. PubMed ID: 23019314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiology of cachexia in chronic obstructive pulmonary disease.
    Schols AM; Gosker HR
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):282-7. PubMed ID: 19713853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic effects in COPD.
    Wouters EF; Creutzberg EC; Schols AM
    Chest; 2002 May; 121(5 Suppl):127S-130S. PubMed ID: 12010840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
    Ju CR; Chen RC
    Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer.
    Puig-Vilanova E; Rodriguez DA; Lloreta J; Ausin P; Pascual-Guardia S; Broquetas J; Roca J; Gea J; Barreiro E
    Free Radic Biol Med; 2015 Feb; 79():91-108. PubMed ID: 25464271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease: effects beyond the lungs.
    Balasubramanian VP; Varkey B
    Curr Opin Pulm Med; 2006 Mar; 12(2):106-12. PubMed ID: 16456379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD.
    Vogiatzis I; Simoes DC; Stratakos G; Kourepini E; Terzis G; Manta P; Athanasopoulos D; Roussos C; Wagner PD; Zakynthinos S
    Eur Respir J; 2010 Aug; 36(2):301-10. PubMed ID: 20110400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cachexia and related components on pulmonary functions in patients with COPD.
    Görek Dilektaşli A; Ulubay G; Bayraktar N; Eminsoy I; Oner Eyüboğlu F
    Tuberk Toraks; 2009; 57(3):298-305. PubMed ID: 19787469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does oxidative stress modulate limb muscle atrophy in severe COPD patients?
    Fermoselle C; Rabinovich R; Ausín P; Puig-Vilanova E; Coronell C; Sanchez F; Roca J; Gea J; Barreiro E
    Eur Respir J; 2012 Oct; 40(4):851-62. PubMed ID: 22408199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
    Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
    Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept.
    Ottenheijm CA; Heunks LM; Dekhuijzen PN
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1233-40. PubMed ID: 17413128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
    Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
    J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waste management - cytokines, growth factors and cachexia.
    Saini A; Al-Shanti N; Stewart CE
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD.
    Remels AH; Schrauwen P; Broekhuizen R; Willems J; Kersten S; Gosker HR; Schols AM
    Eur Respir J; 2007 Aug; 30(2):245-52. PubMed ID: 17459894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.
    Barreiro E; Peinado VI; Galdiz JB; Ferrer E; Marin-Corral J; Sánchez F; Gea J; Barberà JA;
    Am J Respir Crit Care Med; 2010 Aug; 182(4):477-88. PubMed ID: 20413628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diaphragm and skeletal muscle dysfunction in COPD].
    Caron MA; Debigaré R; Dekhuijzen PN; Maltais F
    Rev Mal Respir; 2011 Dec; 28(10):1250-64. PubMed ID: 22152934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease).
    Hansen MJ; Gualano RC; Bozinovski S; Vlahos R; Anderson GP
    Pharmacol Ther; 2006 Jan; 109(1-2):162-72. PubMed ID: 16154635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the beta
    Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
    Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.